Combination hemodialysis and centrifugal therapeutic plasma exchange: 18years of Canadian experience

Hemodialysis International

Volumn 17, Issue 2, 2013, Pages 256-265

  Farah, Myriam ^a   Levin, Adeera ^a   Kiaii, Mercedeh ^a   Vickars, Linda ^a   Werb, Ron ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apheresis; Combination; Hemodialysis; Plasmapheresis; Therapeutic plasma exchange

Indexed keywords

ANTIHISTAMINIC AGENT; CITRIC ACID; FRESH FROZEN PLASMA; GLUCONATE CALCIUM; HEPARIN; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ADULT DISEASE; AGED; ANCA ASSOCIATED VASCULITIS; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD FLOW VELOCITY; CANADA; CONVALESCENCE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL PRURITUS; PATIENT SAFETY; PLASMAPHERESIS; PRURITUS; THERAPEUTIC PLASMA EXCHANGE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; TREATMENT OUTCOME; URTICARIA; VENOUS RETURN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COMPONENT REMOVAL; CANADA; FEMALE; HUMANS; MALE; MIDDLE AGED; PLASMA EXCHANGE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875637643     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00737.x     Document Type: Article

References (17)

1. Ismail N, Kiprov DD, Hakim RM. Plasmapheresis. In: Daugirdas J, Blake P, Ing T, eds. Handbook of Dialysis. Philadelphia, PA: Lippincott Williams & Wilkins. 2007; 275-299.
2. Abel J, Rowntree G, Turner B. Plasma removal with return of corpuscles. J Pharm Exp Ther. 1914; 5:625-641.
3. Denneberg T, Friedberg M, Holmberg L, etal. Combined plasmapheresis and hemodialysis treatment for severe haemolytic-uremic syndrome following campylobacter colitis. Acta Paediatr Scand. 1982; 72:243-245.
4. Siami G, Siami F. Intensive tandem cryofiltration apheresis and hemodialysis to treat a patient with severe calciphylaxis, cryoglobulinemia, and end stage renal disease. ASAIO J. 1999; 45:229-233.
5. Yorgin PD, Eklund DK, Al-Uzri A, Whitesell L, Theodorou AA. Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration. Pediatr Nephrol. 2000; 14:18-21.
6. Bhowmik D, Jain PK, Masih JA, etal. Tandem plasmapheresis and hemodialysis. Ther Apher Dial. 2001; 5:439-441.
7. Mahmood A, Sodano D, Dash A, Weinstein R. Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders. J Clin Apher. 2006; 21:100-104.
8. Perez-Saez MJ, Toledo K, Ojeda R, etal. Tandem plasmapheresis and hemodialysis: Efficacy and safety. Ren Fail. 2011; 33:765-769.
9. Deckman-Sultemeyer T, Linkeschova R, Lenzen K, Kuril Z, Grabensee B. Tandem plasmapheresis and hemodialysis as a safe procedure in 82 patients with immune-mediated disease. Nephrol Dial Transplant. 2009; 24:252-257.
10. Szczepiorkowski ZM, Bandarenko N, Kim HC, etal. Guidelines on the use of therapeutic apheresis in clinical practice-Evidence based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2007; 22:106-175.
11. Cortese I, Chaudry V, So YT, etal. Evidence-based guideline update: Plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011; 76:294-300.
12. Baweja S, Wiggins K, Lee D, etal. Benefits and limitations of plasmapheresis in renal diseases: An evidence-based approach. J Artif Organs. 2011; 14:9-22.
13. Okafor C, Ward D, Mokrzycki M, etal. Introduction and overview of therapeutic apheresis. J Clin Apher. 2010; 25:24-249.
14. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001; 134:1033-1042.
15. Jayne DR, Gaskin G, Rasmussen N, etal. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007; 18:2180-2188.
16. Kiss JE. Thrombotic thrombocytopenic purpura: Recognition and management. Int J Hematol. 2010; 91:36-45.
17. George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23:129-137.